Click Here for 5% Off Your First Aladdin Purchase!

Name And Identifier

ID: ALA1774500

Max Phase: Preclinical

Molecular Formula: C29H32N4O5

Molecular Weight: 516.60

Molecule Type: Small molecule

Representations

Molfile:

Canonical SMILES:

copy

Standard InChI:

copy

Standard InChI Key:

copy

Alternative Forms

  1. Parent:

    ALA1774500

    ---

Molecule Features

Natural Product: NoChemical Probe: No
Molecule Type: Small moleculeFirst In Class: No
Chirality: NoProdrug: No
Oral: NoParenteral: No
Topical: NoBlack Box: No
Availability: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for Indication

Mechanisms of Action

Mechanism of ActionAction TypeTarget NameTarget TypeTarget OrganismBinding Site Name

Activity Summary

Bioactivity SummaryCount
IC502
Inhibition3
F1
Papp1
Ratio IC501
Activity1
Assay SummaryCount
A-ADME2
B-Binding3
F-Functional4

Properties

Molecular Weight: 516.60Molecular Weight (Monoisotopic): 516.2373
AlogP: 2.25#Rotatable Bonds: 6
Polar Surface Area: 97.01Molecular Species: ACID
HBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9
HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.78CX Basic pKa: 7.72
CX LogP: 0.33CX LogD: 0.20
Aromatic Rings: 3Heavy Atoms: 38
QED Weighted: 0.54Np Likeness Score: -0.37

References

1. Kubota K, Kurebayashi H, Miyachi H, Tobe M, Onishi M, Isobe Y..  (2011)  Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines.,  19  (9):   [PMID:21470866]

Source

Source(1):

  • Scientific Literature